• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchSamsung Epis Holdings
    Picture of Samsung Epis Holdings logo

    0126Z0 — Samsung Epis Holdings Share News

    KR₩330,2500.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapSucker Stock
    • Market Cap
      KR₩8tn
    • Enterprise Value
      KR₩8tn
    • Revenue
      KR₩252bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 0126Z0 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    0126Z0 Dividends
    • Brief: Samsung Epis Holdings Says Unit Samsung Bioepis Entered Into Exclusive Supply Agreement Under Brazilian Government Programme For Rare-Disease Treatment

      Yesterday 02:50
    • Brief: Samsung Bioepis, Teva Expand Strategic Partnership To Advance Up To 6 Potential Biosimilar Candidates

      01/10/2026 09:45
    • Brief: Samsung Epis Holdings Co Applies To Korea Food Ministry For Approval Of Pembrolizumab Biosimilar

      10/08/2026 09:05
    • Brief: Samsung Epis Holdings Co Q2 Operating Profit 86.6 Billion Won, Down 3.6% Y/Y

      24/07/2026 07:44

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.